Logo En IconLogo Mark IconIcelandic Intellectual Property Office

SPC351

Ofatúmúmab

  • Status:
    Áfrýjað
  • Application date:
    15.9.2021
  • Application published:
    15.12.2021
  • Max expiry date:
    2.7.2033
  • Medicine name:
    Kesimpta
  • Medicine for children:
    No

Timeline

Today
15.9.2021Application
15.12.2021Publication
2.7.2033Expires

Marketing license

  • IS authorization number:
    EU/1/21/1532/001-002; EU/1/21/1532/003-004
  • Date:
    15.4.2021
  • Foreign authorization number:
    67757-67758
  • Date:
    1.2.2021

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, Basel CH

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að svara niðurstöðu rannsóknar, annar

Deadline until: 01.01.1

Upload documents